Clinical Trials Browser

OTHER × Uterine Cervical Neoplasms × Carboplatin × Clear all

NCT04016389 2025-08-12

FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery

Phase NA Recruiting

Uterine Cervical Neoplasms

NCT06977594 2025-06-24

Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer

Phase NA Not yet recruiting

Uterine Cervical Neoplasms, Drug Hypersensitivity, Ovarian Neoplasms, Endometrial Neoplasms

NCT06942416 2025-04-24

Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer

Phase 2 Recruiting

Uterine Cervical Neoplasms, Neoplasm Recurrence, Local, Neoplasms

NCT03556839 2025-01-08

BEATcc

Phase 3 Active not recruiting

Carcinoma, Uterine Cervical Neoplasms

NCT06752135 2024-12-30

HRCC1

Uterine Cervical Neoplasms

NCT01566240 2024-12-05

INTERLACE

Phase 3 Active not recruiting

Uterine Cervical Neoplasms

NCT04723875 2024-11-01

Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline

Phase 3 Active not recruiting

Uterine Cervical Neoplasms

NCT03367871 2024-06-18

Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer

Phase 2 Terminated

17 enrolled 12 charts

Uterine Cervical Neoplasms

NCT06419673 2024-05-17

Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer

Phase 2 Active not recruiting

Uterine Cervical Neoplasms

NCT06297811 2024-03-07

Myeloprotection With Trilaciclib in Pan-cancer Population

Phase 2 Not yet recruiting

BreastGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT06209294 2024-01-17

Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel/Carboplatin in Fertility Preserving Surgery

Phase 2 Recruiting

Uterine Cervical Neoplasms

NCT00997009 2023-11-14

MITO CERV 2

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT03534713 2023-09-21

ONCOCOL01

Phase 3 Recruiting

Uterine Cervical Neoplasms

NCT05384366 2022-05-20

Neoadjuvant Chemotherapy in Cervical Cancer

Phase 3 Completed

Uterine Cervical Neoplasms, Neoplasms

NCT04772001 2022-05-18

Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer

Phase NA Unknown

Uterine Cervical Neoplasms

NCT05367206 2022-05-10

N6C

Phase 3 Recruiting

Uterine Cervical Neoplasms

NCT05151549 2021-12-09

A Study of Carilizumab Combined With Concurrent Chemoradiotherapy

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT04974944 2021-10-01

First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT04974827 2021-08-10

A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT03852979 2020-01-10

NEOCON-F

Phase 2 Terminated

Uterine Cervical Neoplasms

NCT01523678 2019-07-10

Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers

Phase 2 Completed

Uterine Cervical Diseases, Uterine Cervical Neoplasms, Endocrine System Diseases, Fallopian Tube Diseases, Fallopian Tube Neoplasms, Genital Diseases, Female, Genital Neoplasms, Female, Neoplasms, Neoplasms, Glandular and Epithelial, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Diseases, Peritoneal Neoplasms, Urogenital Neoplasms, Uterine Diseases, Endometrial Neoplasms

NCT00084890 2018-08-10

Docetaxel and Carboplatin in Treating Patients With Recurrent Stage IVB Squamous Cell Carcinoma (Cancer) of the Cervix

Phase 1 Terminated

Uterine Cervical Neoplasms

NCT02629718 2018-03-16

SYSGO-003

Phase 3 Unknown

Uterine Cervical Neoplasms

NCT00600210 2017-08-23

Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer

Phase 2 Withdrawn

Uterine Cervical Neoplasms

NCT01461772 2017-05-31

Efficacy and Safety Study of Concurrent Chemoradiation Therapy to Treat Locally Advanced Cervical Cancer

Phase 3 Terminated

Uterine Cervical Neoplasms

NCT02036164 2017-04-06

ACT-LACC

Phase 3 Unknown

Uterine Cervical Neoplasms

NCT00295789 2016-09-22

Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)

Phase 3 Completed

Uterine Cervical Neoplasms, Recurrence

NCT02515877 2016-06-09

HPV-RX

Phase 1 Completed

Uterine Cervical Neoplasms

NCT02039791 2015-08-19

Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms

NCT01652794 2015-08-04

Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer

Phase 1 Completed

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Leydig Cell Tumor, Pseudomyxoma Peritonei, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT02492503 2015-07-08

Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma Cervix

Phase 1/2 Unknown

Uterine Cervical Neoplasms, Recurrence

NCT02422563 2015-04-21

NACOPRAD

Phase 3 Unknown

Uterine Cervical Neoplasms

NCT02312804 2015-02-16

Ph Ib/BGJ398/Cervix and Other Solid Tumors

Phase 1 Withdrawn

Uterine Cervical Neoplasms, Neoplasms

NCT00807079 2014-10-29

Carboplatin and Topotecan in Treating Patients With Relapsed or Metastatic Cervical Cancer

Phase 1/2 Completed

Uterine Cervical Neoplasms

NCT00032162 2012-05-31

Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer

Phase 1/2 Completed

GynecologicSarcoma

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Sarcoma, Endometrial Neoplasms

NCT00189410 2010-07-20

Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic Tumours

Phase 2 Completed

Uterine Cervical Neoplasms